96436 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
PROTECTED DYE-LABELED REAGENTS
#2MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#3NUCLEIC ACID PRECURSOR
#4Immobilized 4,5-Dicyanoimidazole, and Preparation Method and Application Thereof
#5INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE
#6Beta-D-2'-DEOXY-2'-alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6- SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
#7MODIFIED NUCLEOTIDE REAGENTS
#8SYNTHESIS OF PHOSPHATE DERIVATIVES
#9NUCLEOSIDE-DIPHOSPHATE-HEPTOSE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH ALPK1 ACTIVITY
#10LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING
#11ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF
#12SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION
#13COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS
#144-ETHYNYL-3-HYDROXY-TETRAHYDROFURANYL-ADENINE PHOSPHORAMIDATES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#15MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#16NUCLEOSIDE ANALOGS AND THERAPEUTIC USE THEREOF
#17FRET-LABELED COMPOUNDS AND USES THEREFOR
#18Inhibitors of adenosine 5′-nucleotidase
#194'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE
#20Sting modulator compounds, and methods of making and using
#21PROTECTED DYE-LABELED REAGENTS
#22NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR
#23METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)
#24Modified nucleotide reagents
#25PRODRUGS OF 6-MERCAPTOPURINE
#26β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
#27Antimicrobial compounds, compositions, and uses thereof
#28Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing
#29Compounds for RNA capping and uses thereof
#30CYCLIC DINUCLEOTIDES AS STING AGONISTS
#31ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF
#32A PLATFORM FOR SCREENING NAD+ BINDING PROTEINS IN A CELLULAR CONTEXT
#33SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER COMPOUNDS
#34NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA
#35Substituted nucleosides, nucleotides and analogs thereof
#36METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS
#37Antimicrobial compounds, compositions, and uses thereof
#38Synthesis of phosphate derivatives
#39Protected dye-labeled reagents
#40HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION
#41BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
#42FRET-labeled compounds and uses therefor
#43DERIVATIVES OF GYLCERO-MANNO-HEPTOSE ADP FOR USE IN MODULATING IMMUNE RESPONSE
#44CD73 inhibitor, preparation method therefor and application thereof
#453′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
#46ASYMMETRIC AUXILIARY GROUP
#475'-Cyclo-Phosphonate Modified Nucleotides
#48Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
#496-mercaptopurine nucleoside analogues
#50Modulators of 5′-nucleotidase, ecto and the use thereof
#51ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK
#52Cyclic dinucleotides as sting agonists
#53Method of solid-phase nucleic acid synthesis and solution composition for solid-phase nucleic acid synthesis
#54Prodrugs of glutamine analogs
#55Compounds, compositions, and methods for the treatment of disease
#56SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
#57Method for Using Electrochemical Bioreactor Module with Recovery of Cofactor
#58Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds
#59Sting modulator compounds, and methods of making and using
#60Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing
#61IMPROVED PROCESSES FOR THE PREPARATION OF GUADECITABINE AND INTERMEDIATES THEREOF
#62MODIFIED NUCLEOTIDE TRIPHOSPHATES FOR MOLECULAR ELECTRONIC SENSORS
#63Substituted nucleosides, nucleotides and analogs thereof
#64PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS
#65Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
#66Modulators of 5′-nucleotidase, ecto and the use thereof
#67Asymmetric auxiliary group
#68β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n-substituted purine nucleotides for HCV treatment
#69β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment
#70Methods for the use of 5'-adenosine diphosphate ribose (ADPR)
#71FRET-labeled compounds and uses therefor
#72β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
#73Protected dye-labeled reagents
#74Inhibitors of adenosine 5′-nucleotidase
#753′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
#76Synthesis of 3′-deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)]phosphate (NUC-738)
#77Synthesis of phosphate derivatives
#78NICOTINAMIDE ADENINE DINUCLEOTIDE ANALOGUES
#79Compounds and methods used in assessing mono-PARP activity
#80NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#81Modified nucleotide reagents
#82Substituted nucleosides, nucleotides and analogs thereof
#83Phosphotriazole MRNA 5′-end cap analogs, composition comprising the same, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule, protein or peptide
#84Trinucleotide mRNA cap analogs
#85Substituted nucleosides, nucleotides and analogs thereof
#86SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
#87Malonyl-coenzyme A mimics as fatty acid synthase inhibitors and methods of use
#88Phosphoramidate nucleoside derivatives as anticancer agents
#89Compositions and methods for phosphoramidite and oligonucleotide synthesis
#90Process for purifying NADPH
#91Crystalline 3′,5′-cyclic diguanylic acid
#92Prodrugs of glutamine analogs
#93Prodrugs of glutamine analogs
#94Modulators of 5′-nucleotidase, ecto and the use thereof
#95Materials and Methods for Producing 6-Carbon Monomers
#96MRNA CAP ANALOGS AND METHODS OF MRNA CAPPING
#97Asymmetric auxiliary group
#98β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment
#99Method for liquid-phase synthesis of nucleic acid
#100DIRECT ACTIVITY ASSAYS AND COMPOSITIONS FOR NUCLEOTIDE POOL SANITIZING ENZYMES
#1015′-cyclo-phosphonate modified nucleotides
#102Substituted nucleosides, nucleotides and analogs thereof
#103Method for using electrochemical bioreactor module with recovery of cofactor
#104Fret-labeled compounds and uses therefor
#105Substituted nucleosides, nucleotides and analogs thereof
#106Cyclic dinucleotides as anticancer agents
#107BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#108Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
#109NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#110Prodrugs of glutamine analogs
#111Cyclic di-nucleotides as modulators of STING
#1124′-or nucleosides for the treatment of HCV
#113Method for preparing nicotinamide mononucleotide (NMN)
#114Trinucleotide MRNA cap analogs
#115Substituted nucleosides, nucleotides and analogs thereof
#116β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment
#117β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment
#118β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
#1193′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
#120Modified nucleotide reagents
#121Modulators of 5′-nucleotidase, ecto and the use thereof
#122METHODS (AMACR)
#123LARGE STOKES SHIFT DYES
#124AMPLIFIED ISOTHERMAL DETECTION OF POLYNUCLEOTIDES WITH ATP RELEASE
#125COMPOUNDS AND METHODS USED IN ASSESSING MONO-PARP ACTIVITY
#126Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing
#127Protected dye-labeled reagents
#128Chemical regeneration method of oxidized coenzyme NAD (P)+
#129CRYSTALLINE 3',5'-CYCLIC DIGUANYLIC ACID
#1302' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER
#131Substituted nucleosides, nucleotides and analogs thereof
#132Substituted nucleosides, nucleotides and analogs thereof
#133Nucleotides for the treatment of liver cancer
#134Asymmetric auxiliary group
#135Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase
#136Method for purifying reduced form of β-nicotinamide adenine dinucleotide
#137METHOD FOR PURIFYING OXIDIZED FORM OF BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE
#138Substituted nucleosides, nucleotides and analogs thereof
#139Alkynyl-derivatized cap analogs, preparation and uses thereof
#140D-ALANINE PHOSPHORAMIDE PRONUCLEOTIDES OF 2'-METHYL 2'-FLURO GUANOSINE NUCLEOSIDE COMPOUNDS FOR THE TREATMENT OF HCV
#1414′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication
#142β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment
#143Materials and methods for producing 6-carbon monomers
#144Materials and Methods of Producing 7-Carbon Monomers
#145Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing
#146PHOSPHORIC ACID/PHOSPHONIC ACID DERIVATIVES AND MEDICINAL USES THEREOF
#147Bone targeted therapeutics and methods of making and using the same
#148Compounds useful for FRET and methods related thereto
#149RADICAL ORBITAL SWITCHING
#150SEQUENCING NUCLEIC ACIDS BY ENZYME ACTIVATION
#151Ras inhibitors and uses thereof
#152Substituted nucleosides, nucleotides and analogs thereof
#153Tethering of confactors on graphene-like materials
#154SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
#155N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents
#156Method for liquid-phase synthesis of nucleic acid
#157Substituted nucleosides, nucleotides and analogs thereof
#158Disulfide masked prodrug compositions and methods
#159Alkynyl-derivatized cap analogs, preparation and uses thereof
#160GENETICALLY MODIFIED CELLS AND METHODS FOR MAKING ACTIVATED SUGAR-NUCLEOTIDES
#1614′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication
#162Substituted nucleotide analogs
#163Substituted nucleosides, nucleotides and analogs thereof
#164Large stokes shift dyes
#165Hydrogel-based decontamination of aqueous samples containing nanoparticles
#166Substituted nucleosides, nucleotides and analogs thereof
#1672′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
#168Enzyme function modification method and enzyme variant thereof
#169Thiophosphate nucleosides for the treatment of HCV
#1703′-deoxy nucleosides for the treatment of HCV
#171-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents
#1722′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#173Substituted nucleosides, nucleotides and analogs thereof
#174Substituted nucleosides, nucleotides and analogs thereof
#175Nucleotide analogs and process for making same enzyme
#1762′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
#177Biotinylated compounds
#178Water-soluble camptothecin derivative, pharmaceutical composition and use thereof
#1792′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#180ENZYMATIC SYNTHESIS OF CARBA-NAD
#181Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase
#1822′,4′-bridged nucleosides for HCV infection
#183DINUCLEOTIDE COMPOUNDS FOR HCV INFECTION
#184Fused pentacyclic polyethers
#185Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
#186Bone targeted therapeutics and methods of making and using the same
#187Macrocyclic nucleoside phosphoramidate derivatives
#188Use of 2′,5′-oligoadenylate derivative compounds
#189Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
#190Substituted nucleosides, nucleotides and analogs thereof
#191Substituted nucleotide analogs
#192METHOD OF AMELIORATING OXIDATIVE STRESS AND SUPPLEMENTING THE DIET
#193Alkynyl-derivatized cap analogs, preparation and uses thereof
#194Method for detecting reactants using fluorescent signal intensity
#195Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
#196Compounds and pharmaceutical compositions for the treatment of viral infections
#197METHOD OF TREATING DENGUE FEVER
#198Mononuclear metal complex, hydrogenation reduction catalyst, dehydrogenation catalyst, method for producing hydrogenation reduction product, method for producing hydrogen (H), and method for producing dehydrogenation reaction product
#199Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#2002′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
#2013′-azido purine nucleotide prodrugs for treatment of viral infections
#202Enzymatic synthesis of carba-NAD
#203Fused pentacyclic polyethers
#204NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS
#205Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
#206LARGE STOKES SHIFT DYES
#207Complex and method for enhancing nuclear delivery
#208PROCESS FOR THE ENZYMATIC PRODUCTION OF CYCLIC DIGUANOSINE MONOPHOSPHATE EMPLOYING A DIGUANYLATE CYCLASE COMPRISING A MUTATED RXXD MOTIF
#209Purine nucleoside phosphoramidate
#210Stereoselective synthesis of phosphorus containing actives
#211Method of ameliorating oxidative stress and supplementing the diet
#212Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid
#213COMPOSITIONS, METHODS AND SYSTEMS FOR SINGLE MOLECULE SEQUENCING
#214Water-soluble rhodamine dyes conjugates
#215Drug Transfer Based on Coenzyme A and Acyl Carrier Protein
#216Photocleavable Protecting Groups and Methods for Their Use
#217FRET-labeled compounds and uses therefor
#218Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap
#219METHODS AND COMPOSITIONS FOR CONTINUOUS SINGLE-MOLECULE NUCLEIC ACID SEQUENCING BY SYNTHESIS WITH FLUOROGENIC NUCLEOTIDES
#220Strongly quenching oligomeric excimer/quencher pairs for detection schemes
#221Fused Pentacyclic Polyethers
#222BHQ-caged nucleotide probes photolysable by two-photon excitation
#223Methods for separating carbon nanotubes
#224METHODS AND COMPOSITIONS FOR CONTINUOUS SINGLE-MOLECULE NUCLEIC ACID SEQUENCING BY SYNTHESIS WITH FLUOROGENIC NUCLEOTIDES
#225Nucleosides with antiviral and anticancer activity
#226Water-soluble rhodamine dye conjugates
#227Novel nucleic acid base pair
#228ESTERASES FOR MONITORING PROTEIN BIOSYNTHESIS IN VITRO
#229Bone targeted therapeutics and methods of making and using the same
#230Drug-eluting stents coated with P2Yreceptor antagonist compound
#231Asymmetric disulfides and aryl-alkyl disulfides as anti-bacterial agents
#232Nucleotide analogs
#233Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
#234Fused pentacyclic polyethers
#235Active-site engineering of nucleotidylyltransferases and general enzymatic methods for the synthesis of natural and “unnatural” UDP- and TDP-nucleotide sugars
#236Drug-eluting stents coated with P2Yreceptor antagonist compound
#237Prodrugs for phosphorus-containing compounds
#238Photocleavable protecting groups and methods for their use
#239Nucleic acid base pair
#240Water-soluble rhodamine dye conjugates
#241Fused pentacyclic polyethers
#242Compositions for the treatment of glaucoma or ocular hypertension
#243Bisphosphonate conjugates and methods of making and using the same
#244Method for treating retinal degeneration with purinergic receptor agonists